Dextroamphetamine Sulfate Tablet
FDA Label NDC 0406-8959

33 label sections · Submitted to the FDA by Specgx Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Specgx Llc for the product Dextroamphetamine Sulfate (NDC 0406-8959). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, description, clinical pharmacology, indications and usage, contraindications, abuse, misuse, and addiction, risks to patients with serious cardiac disease, increased blood pressure and heart rate, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.